-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, P73zDG5Dzt3xzjtAXpz7d1h29DQRcOKP5Wc6DsCl2Gsc+Gf1U6WLcSJEfKHhql21 oxZP9qgAt9BZA8z9TQwn/w== 0000940400-06-000156.txt : 20060301 0000940400-06-000156.hdr.sgml : 20060301 20060301114519 ACCESSION NUMBER: 0000940400-06-000156 CONFORMED SUBMISSION TYPE: NSAR-B PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20051231 FILED AS OF DATE: 20060301 DATE AS OF CHANGE: 20060301 EFFECTIVENESS DATE: 20060301 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UBS HEALTH SCIENCES FUND LLC CENTRAL INDEX KEY: 0001116730 IRS NUMBER: 134121400 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NSAR-B SEC ACT: 1940 Act SEC FILE NUMBER: 811-09985 FILM NUMBER: 06653874 BUSINESS ADDRESS: STREET 1: 1285 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2124832323 MAIL ADDRESS: STREET 1: 1285 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: PW HEALTH SCIENCES FUND LLC DATE OF NAME CHANGE: 20000616 NSAR-B 1 ubshealth.fil PAGE 1 000 B000000 12/31/2005 000 C000000 0001116730 000 D000000 N 000 E000000 NF 000 F000000 Y 000 G000000 N 000 H000000 N 000 I000000 6.1 000 J000000 A 001 A000000 UBS HEALTH SCIENCES FUND, LLC 001 B000000 811-09985 001 C000000 8004862608 002 A000000 1285 AVENUE OF THE AMERICAS, 37TH FLOOR 002 B000000 NEW YORK 002 C000000 NY 002 D010000 10019 003 000000 N 004 000000 N 005 000000 N 006 000000 N 007 A000000 N 007 B000000 0 007 C010100 1 007 C010200 2 007 C010300 3 007 C010400 4 007 C010500 5 007 C010600 6 007 C010700 7 007 C010800 8 007 C010900 9 007 C011000 10 008 A000001 UBS FUND ADVISOR LLC 008 B000001 A 008 C000001 801-55537 008 D010001 NEW YORK 008 D020001 NY 008 D030001 10019 008 D040001 6028 010 A000001 PFPC INC. 010 B000001 85-1196 010 C010001 WILMINGTON 010 C020001 DE 010 C030001 19809 011 A000001 UBS FINANCIAL SERVICES, INC. 011 B000001 8-1626700 011 C010001 NEW YORK 011 C020001 NY 011 C030001 10019 012 A000001 PFPC INC. 012 B000001 85-1196 PAGE 2 012 C010001 WILMINGTON 012 C020001 DE 012 C030001 19809 013 A000001 ERNST & YOUNG, LLP 013 B010001 NEW YORK 013 B020001 NY 013 B030001 10036 014 A000001 UBS FINANCIAL SERVICES, INC. 014 B000001 8-1626700 014 A000002 UBS SECURITIES, LLC. 014 B000002 8-55654 015 A000001 PFPC TRUST COMPANY 015 B000001 C 015 C010001 PHILADELPHIA 015 C020001 PA 015 C030001 19153 015 E010001 X 018 000000 Y 019 A000000 Y 019 B000000 14 019 C000000 UBS AIG 020 C000001 0 020 C000002 0 020 C000003 0 020 C000004 0 020 C000005 0 020 C000006 0 020 C000007 0 020 C000008 0 020 C000009 0 020 C000010 0 021 000000 0 022 C000001 0 022 D000001 0 022 C000002 0 022 D000002 0 022 C000003 0 022 D000003 0 022 C000004 0 022 D000004 0 022 C000005 0 022 D000005 0 022 C000006 0 022 D000006 0 022 C000007 0 022 D000007 0 022 C000008 0 022 D000008 0 022 C000009 0 022 D000009 0 022 C000010 0 PAGE 3 022 D000010 0 023 C000000 0 023 D000000 0 024 000000 N 025 D000001 0 025 D000002 0 025 D000003 0 025 D000004 0 025 D000005 0 025 D000006 0 025 D000007 0 025 D000008 0 026 A000000 N 026 B000000 N 026 C000000 N 026 D000000 N 026 E000000 N 026 F000000 N 026 G010000 N 026 G020000 N 026 H000000 N 027 000000 N 028 A010000 0 028 A020000 0 028 A030000 0 028 A040000 0 028 B010000 0 028 B020000 0 028 B030000 0 028 B040000 0 028 C010000 0 028 C020000 0 028 C030000 0 028 C040000 0 028 D010000 0 028 D020000 0 028 D030000 0 028 D040000 0 028 E010000 0 028 E020000 0 028 E030000 0 028 E040000 0 028 F010000 0 028 F020000 0 028 F030000 0 028 F040000 0 028 G010000 0 028 G020000 0 028 G030000 0 028 G040000 0 028 H000000 0 PAGE 4 030 A000000 0 030 B000000 0.00 030 C000000 0.00 031 A000000 0 031 B000000 0 032 000000 0 033 000000 0 035 000000 0 036 B000000 0 038 000000 0 042 A000000 0 042 B000000 0 042 C000000 0 042 D000000 0 042 E000000 0 042 F000000 0 042 G000000 0 042 H000000 0 043 000000 0 044 000000 0 045 000000 Y 046 000000 N 047 000000 N 048 000000 0.000 048 A010000 0 048 A020000 0.000 048 B010000 0 048 B020000 0.000 048 C010000 0 048 C020000 0.000 048 D010000 0 048 D020000 0.000 048 E010000 0 048 E020000 0.000 048 F010000 0 048 F020000 0.000 048 G010000 0 048 G020000 0.000 048 H010000 0 048 H020000 0.000 048 I010000 0 048 I020000 0.000 048 J010000 0 048 J020000 0.000 048 K010000 0 048 K020000 0.000 049 000000 N 050 000000 Y 051 000000 Y 052 000000 N 053 A000000 N PAGE 5 054 A000000 Y 054 B000000 Y 054 C000000 N 054 D000000 N 054 E000000 N 054 F000000 N 054 G000000 N 054 H000000 Y 054 I000000 N 054 J000000 Y 054 K000000 N 054 L000000 N 054 M000000 Y 054 N000000 N 054 O000000 N 055 A000000 N 055 B000000 Y 056 000000 N 057 000000 N 058 A000000 N 059 000000 Y 060 A000000 N 060 B000000 N 061 000000 100000 062 A000000 N 062 B000000 0.0 062 C000000 0.0 062 D000000 0.0 062 E000000 0.0 062 F000000 0.0 062 G000000 0.0 062 H000000 0.0 062 I000000 0.0 062 J000000 0.0 062 K000000 0.0 062 L000000 0.0 062 M000000 0.0 062 N000000 0.0 062 O000000 0.0 062 P000000 0.0 062 Q000000 0.0 062 R000000 0.0 063 A000000 0 063 B000000 0.0 066 A000000 N 067 000000 N 068 A000000 N 068 B000000 N 069 000000 N 070 A010000 Y 070 A020000 Y PAGE 6 070 B010000 Y 070 B020000 N 070 C010000 Y 070 C020000 N 070 D010000 Y 070 D020000 N 070 E010000 Y 070 E020000 N 070 F010000 Y 070 F020000 N 070 G010000 Y 070 G020000 N 070 H010000 Y 070 H020000 N 070 I010000 N 070 I020000 N 070 J010000 Y 070 J020000 Y 070 K010000 Y 070 K020000 Y 070 L010000 Y 070 L020000 N 070 M010000 Y 070 M020000 N 070 N010000 Y 070 N020000 N 070 O010000 Y 070 O020000 Y 070 P010000 Y 070 P020000 N 070 Q010000 Y 070 Q020000 N 070 R010000 Y 070 R020000 N 071 A000000 3000 071 B000000 47789 071 C000000 69649 071 D000000 4 072 A000000 12 072 B000000 41 072 C000000 0 072 D000000 0 072 E000000 0 072 F000000 695 072 G000000 61 072 H000000 0 072 I000000 0 072 J000000 10 072 K000000 0 072 L000000 13 072 M000000 23 PAGE 7 072 N000000 22 072 O000000 44 072 P000000 70 072 Q000000 0 072 R000000 65 072 S000000 50 072 T000000 0 072 U000000 0 072 V000000 0 072 W000000 19 072 X000000 1072 072 Y000000 0 072 Z000000 -1031 072AA000000 6263 072BB000000 0 072CC010000 0 072CC020000 4693 072DD010000 0 072DD020000 0 072EE000000 0 073 A010000 0.0000 073 A020000 0.0000 073 B000000 0.0000 073 C000000 0.0000 074 A000000 1439 074 B000000 0 074 C000000 0 074 D000000 0 074 E000000 0 074 F000000 0 074 G000000 0 074 H000000 0 074 I000000 49707 074 J000000 15623 074 K000000 0 074 L000000 3 074 M000000 0 074 N000000 66772 074 O000000 0 074 P000000 54 074 Q000000 0 074 R010000 0 074 R020000 0 074 R030000 0 074 R040000 11733 074 S000000 0 074 T000000 54985 074 U010000 0 074 U020000 0 074 V010000 0.00 074 V020000 0.00 PAGE 8 074 W000000 0.0000 074 X000000 337 074 Y000000 0 075 A000000 0 075 B000000 70103 076 000000 0.00 077 A000000 Y 077 B000000 Y 078 000000 N 080 A000000 ACE AMERICAN INSURANCE CO. 080 C000000 10000 081 A000000 Y 081 B000000 13 082 A000000 N 082 B000000 0 083 A000000 N 083 B000000 0 084 A000000 N 084 B000000 0 085 A000000 Y 085 B000000 N 086 A010000 0 086 A020000 0 086 B010000 0 086 B020000 0 086 C010000 0 086 C020000 0 086 D010000 0 086 D020000 0 086 E010000 0 086 E020000 0 086 F010000 0 086 F020000 0 088 A000000 N 088 B000000 N 088 C000000 N 088 D000000 N SIGNATURE MICHAEL MASCIS TITLE SENIOR VP EX-99.77B ACCT LTTR 2 ubshealth77b.txt Report of Independent Registered Public Accounting Firm To the Members and Board of Directors of UBS Health Sciences Fund, L.L.C. In planning and performing our audit of the financial statements of UBS Health Sciences Fund, L.L.C. as of and for the year ended December 31, 2005, in accordance with the standards of the Public Company Accounting Oversight Board (United States), we considered its internal control over financial reporting, including control activities for safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-SAR, but not for the purpose of expressing an opinion on the effectiveness of UBS Health Sciences Fund, L.L.C.'s internal control over financial reporting. Accordingly, we express no such opinion. The management of UBS Health Sciences Fund, L.L.C. is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Such internal control includes policies and procedures that provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company's assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. A control deficiency exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A significant deficiency is a control deficiency, or combination of control deficiencies, that adversely affects the company's ability to initiate, authorize, record, process or report financial data reliably in accordance with generally accepted accounting principles such that there is more than a remote likelihood that a misstatement of the company's annual or interim financial statements that is more than inconsequential will not be prevented or detected. A material weakness is a significant deficiency, or combination of significant deficiencies, that results in more than a remote likelihood that a material misstatement of the annual or interim financial statements will not be prevented or detected. Our consideration of UBS Health Sciences Fund, L.L.C.'s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be significant deficiencies or material weaknesses under standards established by the Public Company Accounting Oversight Board (United States). However, we noted no deficiencies in UBS Health Sciences Fund, L.L.C.'s internal control over financial reporting and its operation, including controls for safeguarding securities, that we consider to be a material weakness as defined above as of December 31, 2005. This report is intended solely for the information and use of management and the Board of Directors of UBS Health Sciences Fund, L.L.C. and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. ERNST & YOUNG LLP New York, New York February 20, 2006 -----END PRIVACY-ENHANCED MESSAGE-----